Research progress on risk factors and clinical outcomes of arteriovenous thrombosis after pulmonary surgery
Journal Title: Biomedical Transformation - Year 2024, Vol 5, Issue 1
Abstract
According to 2019 statistical data, the nationwide surgical volume reached 69.3 million patient cases, with pulmonary surgeries constituting a vital component and showing an annual increase. However, as the number of surgeries rises, so does the incidence of perioperative complications, including thrombosis, which adversely affects patient outcomes. Therefore, understanding of the causes, risk factors, and mechanisms of thrombosis in the context of pulmonary surgeries, as well as implementing effective preventive measures, can mitigate the adverse effects of thrombosis related to pulmonary surgeries. This article discusses the incidence, risk factors, clinical manifestations, treatment, and prognosis of postoperative thrombosis in pulmonary surgeries, aiming to provide new insights for related clinical research.
Authors and Affiliations
Teng Meixin, Zhang Jing, Zhang Peng
Keywords
Related Articles
- EP ID EP766045
- DOI 10.12287/j.issn.2096-8965.20240108
- Views 22
- Downloads 0
Identification of environmental etiologies of neurodevelopmental disorders in children
Neurodevelopmental disorders (NDDs) are a group of chronic developmental brain dysfunctions caused by various genetic or acquired factors, characterized by high disability rates and a lack of effective treatments. The et...
Early heparin therapy reduces mortality risk in hyperthermic sepsis patients: A retrospective analysis of the MIMIC-Ⅳ database
Objective To investigate the association between body temperature and coagulation function in septic patients, and to evaluate the effect of early heparin therapy on the prognosis of septic patients across varying temper...
Current studies and potential applications of minimal residual disease in non-small cell lung carcinoma
Long-term recurrences or metastases occur in some patients with non-small cell lung carcinoma after complete remission in the early stages. This phenomenon may be related to the presence of tumor lesions undetectable by...
SARS-CoV-2 vaccine development and challenges
In 2020, the SARS-CoV-2 epidemic has made the world’s public system withstand extreme tests. Therefore, it is urgently expected to develop a vaccine that can effectively prevent the SARS-CoV-2 in the worldwide. At presen...
Research progress of Septin9 and its methylation in malignant tumors
Septin9 is a member of the cytoskeletal GTPase conserved family and is involved in a variety of biological processes. Many studies have shown that Septin9 is related to the occurrence and development of many malignant tu...